NEXGEL, Inc. (NXGLW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$126743.65

MomentumView details →

1D Return

+29.27%

YTD Return

−93.24%

RSI (14)

47.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$126743.65

RSI (14)

47.0

MomentumView details →

1D Return

+29.27%

YTD Return

−93.24%

ProfitabilityView details →

Gross Margin

35.07%

Net Margin

−51.26%

EBITDA Margin

−17.51%

ROE (TTM)

−124.97%

ROA (TTM)

−23.39%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

+3.38%

EPS YoY

−73.17%

FCF YoY

−9.58%

Revenue CAGR 3Y

+77.33%

EPS CAGR 3Y

+24.00%

EBITDA YoY

+6.55%

EarningsView details →

EPS (Actual)

−$0.12

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.24

Avg Surprise (4Q)

−23.22%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

1.51x

Current Ratio

0.43x

Quick Ratio

0.27x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

12.07M

Net Income (TTM)

−6.18M

Op. CF (TTM)

−3.21M

Next earningsNov 17, 2026 →

Latest newsMore news →

NexGel, Inc. appointed Kevin Harris as Chair of the Special Committee for Strategic Review and Value Creation, effective August 20, 2026.15d ago

NEXGEL, Inc. formed a Special Committee for Strategic Review and Value Creation.15d ago

Similar companies

Lucyd, IncLUCYW GlucoTrack, Inc.GCTK Meihua International Medical Technologies Co., Ltd.MHUA NEXGEL, Inc.NXGL Predictive Oncology Inc.POAI WORK Medical Technology Group Ltd.WOK Find similar companies →

Latest newsMore news →

NexGel, Inc. appointed Kevin Harris as Chair of the Special Committee for Strategic Review and Value Creation, effective August 20, 2026.15d ago NEXGEL, Inc. formed a Special Committee for Strategic Review and Value Creation.15d ago NEXGEL, Inc. appointed Brian Kieser as Interim Chief Executive Officer.15d ago